A detailed history of Life Steps Financial, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Life Steps Financial, Inc. holds 7,324 shares of ABBV stock, worth $1.44 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
7,324
Previous 7,365 0.56%
Holding current value
$1.44 Million
Previous $1.34 Million 6.34%
% of portfolio
1.04%
Previous 1.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $6,346 - $7,411
-41 Reduced 0.56%
7,324 $1.26 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $9,429 - $10,743
-59 Reduced 0.79%
7,365 $1.34 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $2,064 - $2,324
15 Added 0.2%
7,424 $1.15 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $801 - $927
6 Added 0.08%
7,409 $1.1 Million
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $1,722 - $2,143
-13 Reduced 0.18%
7,403 $997,000
Q1 2023

Apr 12, 2023

SELL
$144.61 - $166.54 $9,544 - $10,991
-66 Reduced 0.88%
7,416 $1.18 Million
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $22,959 - $27,534
166 Added 2.27%
7,482 $0
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $40,799 - $46,794
304 Added 4.34%
7,316 $982,000
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $79,681 - $101,301
-579 Reduced 7.63%
7,012 $1.07 Million
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $27,715 - $34,387
210 Added 2.85%
7,591 $1.23 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $33,195 - $42,002
-309 Reduced 4.02%
7,381 $999,000
Q3 2021

Oct 06, 2021

BUY
$106.4 - $120.78 $14,044 - $15,942
132 Added 1.75%
7,690 $829,000
Q2 2021

Jul 09, 2021

BUY
$105.21 - $117.21 $129,408 - $144,168
1,230 Added 19.44%
7,558 $851,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $156,109 - $171,858
1,526 Added 31.78%
6,328 $685,000
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $19,076 - $25,754
237 Added 5.19%
4,802 $515,000
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $171 - $201
2 Added 0.04%
4,565 $400,000
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $78,652 - $105,248
1,072 Added 30.71%
4,563 $448,000
Q1 2020

May 21, 2020

BUY
$64.5 - $97.79 $25,800 - $39,116
400 Added 12.94%
3,491 $266,000
Q4 2019

Jan 30, 2020

BUY
$72.13 - $90.25 $222,953 - $278,962
3,091 New
3,091 $274,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Life Steps Financial, Inc. Portfolio

Follow Life Steps Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Steps Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Life Steps Financial, Inc. with notifications on news.